Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Sep 17;21(18):6837.
doi: 10.3390/ijms21186837.

The Role of Cancer-Associated Fibroblasts and Extracellular Vesicles in Tumorigenesis

Issraa Shoucair  1 , Fernanda Weber Mello  1   2 , James Jabalee  1 , Saeideh Maleki  1 , Cathie Garnis  3
Affiliations
Review

The Role of Cancer-Associated Fibroblasts and Extracellular Vesicles in Tumorigenesis

Issraa Shoucair et al. Int J Mol Sci. .

Abstract

Extracellular vesicles (EVs) play a key role in the communication between cancer cells and stromal components of the tumor microenvironment (TME). In this context, cancer cell-derived EVs can regulate the activation of a CAF phenotype in TME cells, which can be mediated by several EV cargos (e.g., miRNA, proteins, mRNA and lncRNAs). On the other hand, CAF-derived EVs can mediate several processes during tumorigenesis, including tumor growth, invasion, metastasis, and therapy resistance. This review aimed to discuss the molecular aspects of EV-based cross-talk between CAFs and cancer cells during tumorigenesis, in addition to assessing the roles of EV cargo in therapy resistance and pre-metastatic niche formation.

Keywords: cancer-associated fibroblasts; extracellular vesicles; neoplasms; tumor microenvironment.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Schematic representation of microvesicles (MVs) and exosomes’ biogenesis and release by eukaryotic cells. MVs are formed after an outward blebbing of the plasma membrane (PM) and are usually sized between 150 and 1000 nm. Exosome (30–150 nm) formation begins in late endosomes that maturate into multivesicular bodies (MVB), including the formation of intervesicular bodies (ILVs) through the inward budding of the MVs limiting membrane. MVB can fuse with the plasma membrane and release the ILVs into the extracellular space as exosomes. Alternatively, MVB can suffer degradation by fusing with lysosomes. EVs can contain numerous biomolecules, including protein, lipids, DNA, and RNA.
Figure 2
Figure 2
Summary of the extra-cellular vesicle (EVs)-mediated cross-talk between cancer cells and cancer-associated fibroblasts (CAFs). Cancer cells can influence stromal cells to activate a CAF phenotype through the release of EVs, which carry several cargos, including proteins, micro-RNAs (miRNA), and long noncoding-RNA (lncRNA). Specific cancer cells-derived EV cargos can also influence a pro-angiogenic or pro-inflammatory phenotype in CAF, and the induction of therapy resistance and pre-metastatic niche formation. At the same time, CAF-derived EVs cargos can influence cancer cells to increase epithelial-to-mesenchymal transition (EMT), growth, invasion, metastasis, motility, stemness, colony formation, apoptosis inhibition, glycolysis, and therapy resistance.
See this image and copyright information in PMC

References

    1. Hanahan D., Weinberg R.A. Hallmarks of cancer: The next generation. Cell. 2011;144:646–674. doi: 10.1016/j.cell.2011.02.013. - DOI - PubMed
    1. Sasahira T., Kirita T. Hallmarks of cancer-related newly prognostic factors of oral squamous cell carcinoma. Int. J. Mol. Sci. 2018;19:2413. doi: 10.3390/ijms19082413. - DOI - PMC - PubMed
    1. Francoa P.I.R., Rodrigues A.P., de Menezes Leite L.B., Miguel M.P. Tumor microenvironment components: Allies of cancer progression. Pathol. Res. Pract. 2019:152729. doi: 10.1016/j.prp.2019.152729. - DOI - PubMed
    1. Hinshaw D.C., Shevde L.A. The tumor microenvironment innately modulates cancer progression. Cancer Res. 2019;79:4557–4566. doi: 10.1158/0008-5472.CAN-18-3962. - DOI - PMC - PubMed
    1. Sahai E., Astsaturov I., Cukierman E., DeNardo D.G., Egeblad M., Evans R.M., Fearon D., Greten F.R., Hingorani S.R., Hunter T. A framework for advancing our understanding of cancer-associated fibroblasts. Nat. Rev. Cancer. 2020:1–13. doi: 10.1038/s41568-019-0238-1. - DOI - PMC - PubMed

MeSH terms